Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer

被引：0
|
作者：
Cochereau, D. [1 ]
Cottu, P. [1 ]
机构：
[1] Inst Curie, F-75005 Paris, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 04期
关键词：
CHEMOTHERAPY;
D O I：
10.1007/s10269-015-2511-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：194 / 196
页数：3
相关论文
共 50 条
  • [1] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
    Tolaney, Sara M.
    Barry, William T.
    Dang, Chau T.
    Yardley, Denise A.
    Moy, Beverly
    Marcom, P. Kelly
    Albain, Kathy S.
    Rugo, Hope S.
    Ellis, Matthew
    Shapira, Iuliana
    Wolff, Antonio C.
    Carey, Lisa A.
    Overmoyer, Beth A.
    Partridge, Ann H.
    Guo, Hao
    Hudis, Clifford A.
    Krop, Ian E.
    Burstein, Harold J.
    Winer, Eric P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 134 - 141
  • [2] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer (vol 372, 134, 2015)
    不详
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (20): : 1989 - 1989
  • [3] Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
    Hajjar, Ali
    Ergun, Mehmet A.
    Alagoz, Oguzhan
    Rampurwala, Murtuza
    [J]. PLOS ONE, 2019, 14 (06):
  • [4] Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
    McArthur, Heather L.
    Mahoney, Kathleen M.
    Morris, Patrick G.
    Patil, Sujata
    Jacks, Lindsay M.
    Howard, Jane
    Norton, Larry
    Hudis, Clifford A.
    [J]. CANCER, 2011, 117 (24) : 5461 - 5468
  • [5] A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)
    Tolaney, S. M.
    Barry, W. T.
    Dang, C. T.
    Yardley, D. A.
    Moy, B.
    Marcom, P. K.
    Albain, K. S.
    Rugo, H. S.
    Ellis, M.
    Shapira, I.
    Wolff, A. C.
    Carey, L. A.
    Overmoyer, B. A.
    Partridge, A. H.
    Guo, H.
    Hudis, C. A.
    Krop, I. E.
    Burstein, H. J.
    Winer, E. P.
    [J]. CANCER RESEARCH, 2013, 73
  • [6] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer
    Morris, Patrick G.
    McArthur, Heather L.
    [J]. ONCOLOGIST, 2012, 17 (10): : E33 - E33
  • [7] Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers.
    McArthur, H. L.
    Mahoney, K.
    Morris, P. G.
    Patil, S.
    Jacks, L. M.
    Howard, J.
    Norton, L.
    Hudis, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer In Reply
    Connolly, Roisin M.
    Bardia, Aditya
    [J]. ONCOLOGIST, 2012, 17 (10): : E34 - E34
  • [9] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 361 - 371
  • [10] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    [J]. Breast Cancer Research and Treatment, 2016, 158 : 361 - 371
12345